Autoimmune diseases, asthma and risk of haematological malignancies:: A nationwide case-control study in Sweden

被引:89
作者
Soderberg, Karin C.
Jonsson, Fredrik
Winqvist, Ola
Hagmar, Lars
Feychting, Maria
机构
[1] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Univ Lund Hosp, S-22185 Lund, Sweden
关键词
leukaemia; lymphoma; multiple myeloma; asthma; autoimmune diseases; risk factors;
D O I
10.1016/j.ejca.2006.04.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
To investigate potential associations between several autoimmune diseases and haematological malignancies, we studied 39,908 cases of leukaemia, Hodgkin's disease, non-Hodgkin's lymphoma and myeloma that occurred during 1987-1999 in Sweden, and 149,344 controls. Hospital discharge diagnoses of psoriasis, Sjogren's syndrome, autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura, pernicious anaemia, multiple sclerosis, rheumatic fever or asthma from 1969 to 1999 were retrieved from the Swedish Hospital Discharge Registry. Psoriasis was positively associated with leukaemia, excluding chronic lymphocytic leukaemia, (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.1-2.3) and non-Hodgkin's lymphoma (OR = 1.6, 95% CI 1.3-2.1). Sjogren's syndrome increased the risks of all haematological malignancies combined (OR = 4.0, 95% CI 2.3-7.0), and of non-Hodgkin's lymphoma (OR = 6.4, 95% CI 3.5-12). These findings, together with increased risks of several haematological malignancies in autoimmune haemolytic anaemia and idiopathic thrombocytopenic purpura but not in asthma, suggest chronic autoimmunity and immune stimulation as mechanisms contributing to the development of haematological malignancies.
引用
收藏
页码:3028 / 3033
页数:6
相关论文
共 29 条
[1]
Björnådal L, 2002, SCAND J RHEUMATOL, V31, P66
[2]
Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden [J].
Boffetta, P ;
Gridley, G ;
Lindelöf, B .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1531-1537
[3]
CANCER RISK FOLLOWING PERNICIOUS-ANEMIA [J].
BRINTON, LA ;
GRIDLEY, G ;
HRUBEC, Z ;
HOOVER, R ;
FRAUMENI, JF .
BRITISH JOURNAL OF CANCER, 1989, 59 (05) :810-813
[4]
BURNET FM, 1957, BRIT MED J, V1, P844
[5]
GENETIC-FACTORS PREDISPOSING TO CHRONIC LYMPHOCYTIC-LEUKEMIA AND TO AUTOIMMUNE-DISEASE [J].
CONLEY, CL ;
MISITI, J ;
LASTER, AJ .
MEDICINE, 1980, 59 (05) :323-334
[6]
Cooper GS, 1996, CANCER EPIDEM BIOMAR, V5, P867
[7]
Diehl LF, 1998, SEMIN ONCOL, V25, P80
[8]
LEUKEMIA, LYMPHOMA, AND MULTIPLE-MYELOMA FOLLOWING SELECTED MEDICAL CONDITIONS [J].
DOODY, MM ;
LINET, MS ;
GLASS, AG ;
FRIEDMAN, GD ;
POTTERN, LM ;
BOICE, JD ;
FRAUMENI, JF .
CANCER CAUSES & CONTROL, 1992, 3 (05) :449-456
[9]
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: A case-control study [J].
Engels, EA ;
Cerhan, JR ;
Linet, MS ;
Cozen, W ;
Colt, JS ;
Davis, S ;
Gridley, G ;
Severson, RK ;
Hartge, P .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (12) :1153-1161
[10]
Eriksson NE, 2005, J INVEST ALLERG CLIN, V15, P161